LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | CP724714 | 10 | uM | LJP5 | 3 | A07 | 72 | hr | 1235 | 2135 | 4326 | 0.4935 | 0.3533 |
MCF7 | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 1235 | 2443 | 4326 | 0.5647 | 0.4580 |
MCF7 | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 1235 | 1858 | 4356 | 0.4265 | 0.2517 |
MCF7 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 1235 | 1963 | 4326 | 0.4537 | 0.2919 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1235 | 2903 | 4119 | 0.7048 | 0.6352 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 1235 | 2660 | 4356 | 0.6106 | 0.5248 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1235 | 2301 | 4326 | 0.5319 | 0.4105 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1235 | 1076 | 4326 | 0.2487 | -0.0735 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 2 | J06 | 72 | hr | 1235 | 4880 | 4356 | 1.1202 | 1.1289 |
MCF7 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1235 | 923 | 4326 | 0.2133 | -0.1489 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1235 | 1295 | 4119 | 0.3144 | 0.0275 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 1235 | 1226 | 4356 | 0.2814 | -0.0042 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1235 | 1300 | 4326 | 0.3005 | 0.0286 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 1235 | 3684 | 4356 | 0.8457 | 0.8239 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 3 | B18 | 72 | hr | 1235 | 1361 | 4326 | 0.3146 | 0.0550 |
MCF7 | Tozasertib | 0.12 | uM | LJP5 | 1 | B17 | 72 | hr | 1235 | 1405 | 4119 | 0.3411 | 0.0769 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1235 | 931 | 4119 | 0.2260 | -0.1503 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 1235 | 913 | 4356 | 0.2096 | -0.1532 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1235 | 876 | 4326 | 0.2025 | -0.1731 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1235 | 1502 | 4356 | 0.3448 | 0.1135 |
MCF7 | Seliciclib | 10 | uM | LJP5 | 2 | J01 | 72 | hr | 1235 | 687 | 4356 | 0.1577 | -0.2759 |
MCF7 | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1235 | 1519 | 4119 | 0.3688 | 0.1263 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1235 | 1004 | 4119 | 0.2437 | -0.1125 |
MCF7 | AZD-6482 | 0.12 | uM | LJP5 | 2 | I05 | 72 | hr | 1235 | 4063 | 4356 | 0.9327 | 0.9248 |
MCF7 | AZD-6482 | 0.12 | uM | LJP5 | 1 | I05 | 72 | hr | 1235 | 3646 | 4119 | 0.8851 | 0.8643 |